Summary of Tongcheng Travel Holdings Conference Call Company Overview - **Company**: Tongcheng Travel Holdings (Ticker: 0780.HK) - **Industry**: China Internet and Other Services - **Market Cap**: Rmb 37,149 million - **Current Stock Price**: HK$18.00 - **Price Target**: HK$29.00, representing a 61% upside potential Key Takeaways Travel Demand and Market Position - Overall travel demand is solid, with positive hotel RevPAR in CNY and favorable pre-booking trends for Qingming [1] - Management believes fears regarding AI routing are exaggerated, asserting that the core competitiveness of OTAs lies in their supply chain depth and service capabilities [1] - Content platforms primarily serve as travel inspiration, while consumers with clear intent prefer OTAs over AI chatbots [1] - Tongcheng plans to collaborate with chatbots to capture additional traffic, emphasizing that service capabilities are challenging to replace due to the complex value chain involved in delivery [1] Financial Metrics and Projections - The overall take rate is expected to remain stable in 2026, with transportation take rate around 4% and air ticket take rate between 3.5% and 4% [2] - Hotel take rate is projected to stabilize at 9-10% [2] - Following the acquisition of Wanda Hotel Management, Tongcheng aims to open 100 new hotels and sign 300 in 2026, focusing on higher-tier cities with an average daily rate (ADR) of Rmb 400-500 [3] - This expansion is anticipated to drive revenue acceleration, although margins may be pressured by upfront costs associated with new hotel openings [3] Financial Forecasts - **Fiscal Year Ending**: - 2025: Revenue of Rmb 19,396 million, EPS of 1.46 - 2026: Revenue of Rmb 21,620 million, EPS of 1.67 - 2027: Revenue of Rmb 23,661 million, EPS of 1.86 - 2028: Revenue of Rmb 25,369 million, EPS of 2.01 [4] Valuation and Risks - WACC is estimated at 11.5%, slightly higher than TCOM due to its smaller size, with a terminal growth rate of 3% aligned with long-term GDP growth targets [7] - **Upside Risks**: Strong pent-up demand and moderating competition in lower-tier cities could lead to lower subsidies and margin upside [8] - **Downside Risks**: Softer macroeconomic growth in China may impact price-sensitive users in lower-tier cities, alongside intensifying competition in those areas [8] Additional Insights - The company maintains an attractive industry view, with a stock rating of Overweight [4] - Average daily trading value is HK$251 million, indicating active market participation [4] - The company’s financial metrics suggest a strong growth trajectory, with increasing EPS and revenue forecasts over the next few years [4] This summary encapsulates the critical insights from the conference call, highlighting the company's strategic positioning, financial outlook, and market dynamics.

Investment Rating - The report maintains a "Buy" rating for the company [8]. Core Insights - The current competitive landscape for OTA (Online Travel Agency) is stabilizing, with the company focusing on enhancing operational efficiency. The company's profitability is on an upward trajectory due to optimized user marketing strategies, refined subsidies, and improved outbound travel profitability. There is still room for improvement in sales expense ratios and take rates, which are expected to support sustained profit margin growth [2][6]. - For the fiscal year 2025, the company achieved a revenue of 48.40 billion yuan, representing a year-on-year increase of 14.2%, and an adjusted net profit of 7.80 billion yuan, up 18.1% year-on-year. The total revenue for 2025 was 193.96 billion yuan, with a year-on-year growth of 11.9%, and an adjusted net profit of 34.03 billion yuan, reflecting a 22.2% increase year-on-year [6][8]. Summary by Sections Revenue and Profitability - In Q4 2025, the company reported accommodation booking revenue of 13.10 billion yuan, a year-on-year increase of 15.4%, driven by record overnight stays and a shift towards higher-quality hotels. The transportation revenue for Q4 was 18.36 billion yuan, up 6.5% year-on-year, with growth supported by cross-selling and value-added products [6][8]. - The hotel management business saw significant growth, with other income rising 53% to 9.17 billion yuan in Q4, primarily due to the expansion of hotel management and the consolidation of Wanda Hotels [6][8]. Future Projections - The company forecasts overall revenues of 219.15 billion yuan, 246.87 billion yuan, and 277.77 billion yuan for 2026, 2027, and 2028, respectively. Adjusted net profits are expected to be 39.28 billion yuan, 43.52 billion yuan, and 48.18 billion yuan for the same years, corresponding to a price-to-earnings ratio of 10, 9, and 8 times [2][6].

Investment Rating - The report maintains an "Overweight" rating for the overseas pharmaceutical industry, indicating a positive outlook compared to the overall market performance [56]. Core Insights - The report highlights that 2025 will see concentrated performance releases across the overseas pharmaceutical sector, with companies like Kelun-Biotech, WuXi AppTec, and Fuhong Hanlin showing significant revenue growth and expanding product pipelines [2][12][15]. - Kelun-Biotech's revenue increased by 6.5% to 2.06 billion CNY, while its product sales surged by 949.8% to 543 million CNY, indicating strong market traction [7][8]. - WuXi AppTec reported a robust revenue growth of 46.7% to 5.94 billion CNY, driven by increased capacity utilization and operational efficiency [12][13]. - Fuhong Hanlin's revenue grew by 16.5% to 6.67 billion CNY, with a notable increase in R&D expenses, reflecting a commitment to innovation [15][16]. Summary by Sections Overseas Pharmaceuticals - The report notes that the Hang Seng Healthcare Index fell by 3.23%, underperforming the Hang Seng Index by 0.70 percentage points [6]. - Kelun-Biotech's core pipeline, Sac-TMT, is progressing well overseas, with multiple key clinical trials initiated [9][10]. - WuXi AppTec's market share increased from 21.7% in 2024 to over 24% in 2025, with a significant rise in unfulfilled orders [13][14]. Fuhong Hanlin - Fuhong Hanlin's global product revenue reached 5.82 billion CNY, with overseas sales exceeding 2 billion CNY, reflecting a strong international presence [15][16]. - The company is actively advancing clinical development for its innovative products, including HLX43 and HLX22, which target various cancers [16][17]. Investment Recommendations - The report suggests focusing on companies like Kelun-Biotech and WuXi AppTec due to their strong growth trajectories and expanding product lines [29]. - It also highlights the potential of Fuhong Hanlin's innovative pipeline and its commitment to R&D as key factors for future growth [15][16].

Group 1 - The report highlights that Chaoyun Group has maintained high dividends for six consecutive years, with revenue and profit both showing year-on-year growth, indicating a sustainable growth outlook for its product matrix [4][5] - In 2025, Chaoyun Group achieved a revenue of 1.988 billion RMB, a year-on-year increase of 9.24%, and a net profit of 224 million RMB, up 9.98% year-on-year, with a comprehensive gross margin of 52.61% [4][5] - The company’s home care products performed well, with revenue from this segment reaching 1.715 billion RMB, a year-on-year increase of 5.0%, while the pet business saw a significant growth of 74.3% [5][6] Group 2 - Jianmin Group's revenue for 2025 was 3.370 billion RMB, a decrease of 3.85% year-on-year, but the fourth quarter showed a strong recovery with an 82.69% increase in net profit [10][11] - The pharmaceutical industrial segment of Jianmin Group reported a revenue of 2.025 billion RMB, a year-on-year increase of 15.91%, driven by strong sales of prescription and OTC products [11][12] - The company is focusing on brand development and innovation, with key products showing significant sales growth, indicating a strong recovery in its core business [11][12] Group 3 - The report on Yimeng Biotech indicates that the B7H3 ADC drug has shown excellent efficacy in treating metastatic castration-resistant prostate cancer (mCRPC), with promising clinical trial results [13][14] - The drug has received fast track designation from the FDA, highlighting its potential in the market [14][15] - The clinical study included 146 patients, showing a median radiographic progression-free survival of 11.3 months, indicating strong therapeutic potential [15][16] Group 4 - Pop Mart reported a revenue of 37.12 billion RMB in 2025, a year-on-year increase of 184.7%, with adjusted net profit rising by 284.5% [18][19] - The company has seen a significant increase in online sales, which accounted for 44.3% of total revenue, reflecting a shift in consumer purchasing behavior [21][22] - The number of IPs generating over 2 billion RMB in revenue has increased, with the "Star People" IP showing a remarkable growth of 1602% [25][26] Group 5 - CIMC Vehicles reported a revenue of 20.18 billion RMB in 2025, a decrease of 3.9% year-on-year, but with a strong performance in the Chinese market, where semi-trailer sales increased by 15% [28][29] - The company anticipates a recovery in the North American market in 2026, with significant order rebounds indicating a potential turnaround [29][30] - The report emphasizes the company's strategic positioning in the global market, particularly in the southern regions, which are expected to drive future growth [28][29] Group 6 - Power Development reported a revenue of 5.293 billion RMB in 2025, a decrease of 6.4% year-on-year, but maintained a high profit margin despite market challenges [32][33] - The company achieved a high dividend payout ratio of 123%, reflecting its commitment to returning value to shareholders [33][34] - The report outlines ongoing projects that are expected to enhance production capacity significantly in the coming years, indicating strong growth potential [34][35] Group 7 - Bluestar Technology is recognized as a leader in adsorption separation materials, with significant growth driven by innovation and market demand in various sectors [37][38] - The company is positioned to benefit from the growing market for small nucleic acid drugs, with projections indicating substantial growth in this area [38][39] - The report forecasts revenues of 2.733 billion RMB for 2025, with a strong growth trajectory expected in subsequent years [39]

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Insights - The company's revenue growth in Q4 has improved sequentially, driven by an increase in the OTA business's contribution, leading to enhanced profitability. For Q4 2025, revenue is projected at 4.84 billion HKD, representing a 14.2% increase, with net profit attributable to shareholders at 0.08 billion HKD and adjusted profit at 0.78 billion HKD, reflecting an 18.1% increase [8][4]. - The company is focusing on lower-tier market segments, with Q4 revenues from transportation, accommodation, and other services growing by 6.5%, 15.4%, and 53.0% year-on-year, respectively. The average daily rate (ADR) for hotels has continued its positive growth trend since Q2 2025, with a 5 percentage point increase in the share of three-star and above room nights [2][10]. - The company emphasizes its core OTA business and the growth potential of its hotel management segment, which has expanded significantly since 2021. The management expects continued revenue growth and improved profitability in the hotel management business through operational efficiency enhancements driven by AI technology [11][3]. Summary by Relevant Sections Financial Performance - For 2025, the company anticipates total revenue of 19.4 billion HKD (+11.9%) and net profit of 2.4 billion HKD (+20.1%), with adjusted net profit reaching 3.4 billion HKD (+22.2%). The OTA business's growth rate has increased to 17.5%, primarily due to the hotel management segment [8][4]. - The company plans to maintain a dividend of 0.25 HKD per share, with payout ratios of 24% for net profit and 17% for adjusted net profit [8]. Business Segmentation - The hotel booking segment is undergoing structural upgrades, with international business balancing revenue and profit. The hotel management business is highlighted as a significant growth driver, with the company managing 3,000 hotels following the integration of Wanda Hotel Management [11][3]. - The company expects the share of outbound tourism to increase from 5-6% to 10-15% of total transportation and accommodation revenue by 2025 [11]. Future Outlook - The company has revised its adjusted net profit forecasts for 2025-2028 to 4.0 billion, 4.6 billion, and 5.2 billion HKD, respectively, with corresponding dynamic P/E ratios of 10, 9, and 8 times. The tourism sector is expected to benefit from optimized holiday policies, supporting short-term performance [4][12].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 20% compared to the market benchmark within the next six months [19]. Core Insights - The company has demonstrated robust growth in its core OTA revenue and adjusted net profit, with Q4 2025 revenue reaching 4.84 billion yuan, a 14.2% increase year-on-year, and core OTA revenue at 4.06 billion yuan, up 17.5% [3][5]. - The adjusted net profit for Q4 2025 was 780 million yuan, reflecting an 18.1% year-on-year growth, while the full-year revenue for 2025 was 19.4 billion yuan, marking an 11.9% increase [3][5]. - The company is positioned as a leading OTA in the lower-tier market, benefiting from strong backing by Tencent and Ctrip, which enhances its competitive advantage in domestic and international markets [7]. Financial Performance - In Q4 2025, the core OTA operating profit was 1.15 billion yuan, with an operating profit margin (OPM) of 28.4%, remaining stable year-on-year [5]. - The traffic business generated 1.84 billion yuan in revenue, a 6.5% increase, while accommodation revenue reached 1.31 billion yuan, up 15.4% [5]. - The company achieved a record high in annual service users, with 250 million paid users, a 6.0% increase year-on-year, and total service instances reaching 2.03 billion, a 5.5% increase [6]. Profit Forecast and Valuation - The company is expected to see continued profit improvement, with projected net profits for 2026, 2027, and 2028 at 3.3 billion, 4.0 billion, and 4.7 billion yuan respectively, corresponding to P/E ratios of 12, 10, and 8 times [7]. - The forecasted revenue growth rates for the upcoming years are 12.9% for 2026, 11.7% for 2027, and 10.8% for 2028, indicating a stable growth trajectory [13].

Investment Rating - The report maintains an "Outperform" rating for the company [6][4] Core Insights - The company's revenue growth in Q4 shows an improvement, driven by an increase in OTA business share, leading to enhanced profitability. Q4 revenue is projected at HKD 4.84 billion, representing a 14.2% increase, with net profit attributable to shareholders at HKD 80 million, and adjusted profit at HKD 780 million, reflecting an 18.1% increase [8][4] - The company is focusing on lower-tier market segments, with Q4 revenue from transportation, accommodation, and other services growing by 6.5%, 15.4%, and 53.0% respectively. The average daily rate (ADR) for hotels continues to show positive growth, with a 5 percentage point increase in the share of three-star and above room nights [10][2] - The company emphasizes the expansion of its hotel management business as a new growth engine, with expectations for significant revenue growth and improved profitability in the coming years. The integration of Wanda Hotel Management has resulted in the management of 3,000 hotels, and the company anticipates that the hotel management business will continue to grow positively [11][3] Summary by Sections Financial Performance - For 2025, the company expects total revenue of HKD 19.4 billion, a growth of 11.9%, with net profit projected at HKD 2.4 billion, reflecting a 20.1% increase. Adjusted net profit is forecasted at HKD 3.4 billion, up 22.2% [8][4] - The company plans to maintain a dividend of HKD 0.25 per share, with payout ratios of 24% for net profit and 17% for adjusted net profit [8][4] Business Segments - The hotel booking segment is undergoing structural upgrades, with international business balancing revenue and profit. The hotel management business is showing significant growth, supported by the integration of Wanda Hotel Management [10][3] - The company is also seeing a shift towards outbound tourism, with expectations that the share of outbound travel will increase from 5-6% to 10-15% of total transportation and accommodation revenue by 2025 [11][3] Future Outlook - The report projects adjusted net profits for 2025-2028 at HKD 40.0 billion, 46.1 billion, and 52.1 billion respectively, with corresponding dynamic P/E ratios of 10, 9, and 8 times [4][12] - The company is expected to benefit from improved operational efficiency through AI technology, which will enhance profit margins and support the growth of the hotel management business [11][3]

Investment Rating - The report maintains a "Buy" rating for the company [7][11]. Core Insights - The adjusted performance for Q4 2025 met expectations, with the core OTA business continuing to grow steadily, while the travel agency business faced one-time impairment risks [2][3]. - Revenue for Q4 2025 reached 4.84 billion RMB, a year-on-year increase of 14.22%. The adjusted net profit was 780 million RMB, up 18.12% year-on-year [11]. - The report anticipates an increase in international business and domestic peak season marketing investments, leading to an upward revision of the 2027 adjusted net profit forecast to 4.938 billion RMB [11]. Financial Summary - **Revenue Forecast (Million RMB)**: - 2024A: 17,341 - 2025A: 19,396 (+11.85%) - 2026E: 21,856 (+12.68%) - 2027E: 24,467 (+11.94%) - 2028E: 26,634 (+8.86%) [4] - **Net Profit Forecast (Million RMB)**: - 2024A: 1,974 - 2025A: 2,371 - 2026E: 3,372 - 2027E: 4,387 - 2028E: 5,239 [4] - **Adjusted Net Profit Forecast (Million RMB)**: - 2024A: 2,785 - 2025A: 3,403 - 2026E: 4,038 - 2027E: 4,938 - 2028E: 5,730 [4] - **Adjusted EBITDA (Million RMB)**: - 2024A: 4,050 - 2025A: 5,138 - 2026E: 5,974 - 2027E: 7,122 - 2028E: 8,208 [4] - **Adjusted EBITDA Margin (%)**: - 2025A: 29.65% - 2026E: 26.85% - 2027E: 16.27% - 2028E: 19.23% [4] Market Data - Current stock price: 18.44 HKD - Market capitalization: 43.41 billion HKD - 52-week price range: 18.08 - 25.32 HKD [8].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return exceeding the market benchmark by more than 15% over the next 6-12 months [5]. Core Insights - The company reported a revenue of 19.396 billion yuan for 2025, a year-on-year increase of 11.9%, and an adjusted net profit of 3.403 billion yuan, up 22.2% year-on-year, with an adjusted net profit margin of 17.5%, an increase of 1.5 percentage points [1][3]. - The core OTA business showed steady growth, with Q4 revenue reaching 4.062 billion yuan, a 17.5% increase year-on-year, driven by new accommodation scenarios and a shift towards high-quality hotels [1]. - The company is leveraging AI technology to enhance customer service efficiency and user experience, contributing to a gross margin of 65.9% in Q4, up 2.4 percentage points year-on-year [2]. Summary by Relevant Sections Financial Performance - In Q4 2025, the company achieved a revenue of 4.840 billion yuan, a 14.2% increase year-on-year, and an adjusted net profit of 780 million yuan, up 18.1% year-on-year, slightly exceeding guidance [1]. - The adjusted net profit margin for Q4 was 16.1%, an increase of 0.5 percentage points year-on-year [1]. Business Segments - Accommodation booking revenue in Q4 reached 1.310 billion yuan, a 15.4% increase year-on-year, supported by the integration of new accommodation scenarios [1]. - Transportation ticketing revenue for Q4 was 1.836 billion yuan, a 6.5% increase year-on-year, benefiting from system upgrades and balanced growth in international ticketing [1]. - Other business revenue in Q4 was 917 million yuan, a significant 53.0% increase year-on-year, driven by the integration of Wanda Hotels and the performance of the eLong hotel technology platform [1]. - Vacation revenue in Q4 was 778 million yuan, slightly down by 0.3% year-on-year, outperforming guidance [1]. Profitability Forecast - The adjusted net profit for 2026 is projected to be 3.899 billion yuan, with a growth rate of 14.6%, and for 2027, it is expected to reach 4.483 billion yuan, with a growth rate of 15.0% [4]. - The company anticipates that its international business and hotel management will contribute significantly to profit growth, with expectations of over 100 million yuan in profit from hotel management [2][3].

Investment Rating - The report maintains a "Strong Buy" rating for the company [1][3] Core Insights - The company achieved revenue of 4.84 billion yuan, representing a year-on-year growth of 14.2%, and adjusted profit of 780 million yuan, up 18.1%, indicating steady revenue growth and performance in line with expectations [1][7] - The domestic travel market has shown steady improvement since Q4, with the hotel business experiencing both volume and price increases, while international operations continue to grow significantly and have begun to achieve profitability [1][7] - The acquisition of Wanda Hotel Management in October has further enhanced the company's hotel and travel industry chain, and ongoing cost reduction and efficiency improvement measures are expected to support continued high growth in future performance [1][7] Financial Performance Summary - For Q4, the company reported revenues from accommodation bookings, transportation ticketing, vacation services, and other businesses of 1.31 billion, 1.84 billion, 780 million, and 920 million yuan respectively, with year-on-year growth rates of 15.4%, 6.5%, 0.3%, and 53.0% [7] - The average monthly paying users reached 41.4 million, a 1.0% increase, while annual paying users grew by 6.0% to 250 million [7] - The gross margin improved to 65.9%, up 2.4 percentage points year-on-year, with adjusted net profit margin at 16.1%, reflecting steady improvement in profitability [7] Financial Projections - The company forecasts main revenue of 17.34 billion yuan for 2024, growing to 27.31 billion yuan by 2028, with a compound annual growth rate of 10% [6][9] - Adjusted net profit is projected to increase from 1.97 billion yuan in 2024 to 4.49 billion yuan in 2028, with a notable growth rate of 27% in 2024 [6][9] - The report anticipates an adjusted earnings per share (EPS) of 1.18 yuan for 2024, increasing to 1.91 yuan by 2028, with a price-to-earnings (P/E) ratio decreasing from 19.2 to 8.5 over the same period [6][10]